Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company GliaCure Inc.
DescriptionSmall molecule that stimulates phagocytosis and anti-inflammatory actions to reduce pro-inflammatory cytokines
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation U.S. - Fast Track (Treat Alzheimer's disease (AD))
PartnerTufts University

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today